 |
NetWellness is a global, community service providing quality, unbiased health information from our partner university faculty. NetWellness is commercial-free and does not accept advertising.
Wednesday, June 19, 2013
|
|
|
NetWellness is a global, community service providing quality, unbiased health information from our partner university faculty. NetWellness is commercial-free and does not accept advertising.
Wednesday, June 19, 2013
|
| Home | HealthTopics | Health Centers | Reference Library | Research |
 Join us on Facebook
|
Share on Facebook | Tweet |
|
Epilepsy |
Rufinamide03/20/2009 |
I`m curious how this drug is doing so far. I realize it was just O.K.`ed in November for Lennox-Gastaut. FDA is expected to approve it soon for onset-seizures. I`ve read before that it has been used in other countries for years, but can`t find about any (if @ all) unexpected effects.
Banzel (rufinamide) was first available in January 2009 to be prescribed for seizures in Lennox-Gastaut syndrome. It may be approved later for other seizures. You can learn more about the side effects and more about the effects on seizures at the website below.
|
David M Ficker, MD Associate Professor College of Medicine University of Cincinnati |
|
|
Please note: only your personal physician or other health professional you consult can best advise you on matters of your health based on your medical history, your family medical history, your medication history, and how information from any of these databases may apply to you. Neither University of Cincinnati (NetWellness) nor any party involved in creating, producing or delivering this web site shall be liable for any damages arising out of access to or use of this web site, or any errors or omissions in the content thereof. (More) 
|